February 17, 2023 02:46 PM EST
People
FDA+

FDA's No. 2 on­col­o­gy of­fi­cial de­parts for biotech start­up

Zachary Brennan

Senior Editor

A qui­et, San Diego-based start­up with hun­dreds of mil­lions to work with just poached the sec­ond in com­mand at FDA’s On­col­o­gy Cen­ter of Ex­cel­lence …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times